arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

ARS Pharmaceuticals, Inc.

SPRY Health Care Biotechnology: Pharmaceutical Preparations
$4.03
▼ -3.6% Today
as of Oct 23, 16:52 ET
Last 30 days -10.44% Sep 14 → Oct 23
$3.88 $4.06 $4.25 $4.43 $4.61 Sep 14 Sep 22 Sep 30 Oct 07 Oct 15 Oct 23
Open
$4.28
High
$4.28
Low
$4.00
Volume
$2M
Avg Vol
$2M
Mkt Cap
$410M
P/E (TTM)
—
Beta
—
52w High
$13.15
52w Low
$3.81
Div Yield
—
Shares Out
$99M

Recent Press Releases & News last 60 days · 1 item

Sep 1 · 20:01 PR GlobeNewswire
ARS Pharmaceuticals to Participate in Upcoming Investor Conferences

SPRY earnings at a glance

The options market is pricing a move of about ±23.0% after the report, a range of roughly $3.10 to $4.96 from today's $4.03. Over its last 2 reports the stock rose the next day 0 times and fell 2, moving ±7.9% on average; after the most recent report on May 15, 2026 it moved -6.5%. That means options currently expect more movement than SPRY has typically delivered. SPRY beat the consensus EPS estimate in 0 of its last 4 reported quarters. Implied volatility is currently 195%. The share price of $4.03 sits near its 52-week low.

More Health Care stocks · All stocks · Earnings calendar

Overview

52-week range
$3.81
$13
2% of range
Avg surprise (last 4)
-10.7%
Avg reaction (last 2)
-7.9%
0% positive
Latest IV / EM
195%
EM ±23.0% · $5 · Oct 16

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.63$-0.50$-0.37$-0.24$-0.11 Actual $-0.16Actual $-0.18Actual $-0.16Actual $-0.11Actual $-0.13Actual $-0.20Actual $-0.35Est $-0.35Actual $-0.46Est $-0.41Actual $-0.52Est $-0.45Actual $-0.61Est $-0.53Actual $-0.63 MarJunSepMarJunSepMar/2025Jun/2025Sep/2025Mar/2026Jun
Revenue vs Net Income Revenue Net income
$-62M$-38M$-13M$11M$35M Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $-0.63 — — — — financials
Fri May 15, 2026Mar/2026 $-0.61 $-0.53 -15.1% -74.3% -6.5% earnings
Mon Nov 10, 2025Sep/2025 $-0.52 $-0.45 -15.6% — — earnings
Wed Aug 13, 2025Jun/2025 $-0.46 $-0.41 -12.2% — — earnings
Wed May 14, 2025Mar/2025 $-0.35 $-0.35 0.0% — -9.4% earnings
Mon Sep 30, 2024Sep 2024 $-0.20 — — — — financials
Sun Jun 30, 2024Jun 2024 $-0.13 — — — — financials
Sun Mar 31, 2024Mar 2024 $-0.11 — — — — financials
Sat Sep 30, 2023Sep 2023 $-0.16 — — — — financials
Fri Jun 30, 2023Jun 2023 $-0.18 — — — — financials
Fri Mar 31, 2023Mar 2023 $-0.16 — — — — financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$34M$23M—$33M$16M$8M—$2M
Cost of revenue————————
Gross profit————————
Operating income$-61M$-60M—$-53M$-48M$-37M—$-22M
Net income$-62M$-61M—$-51M$-45M$-34M—$-19M
EPS (diluted)$-0.63$-0.61—$-0.52$-0.46$-0.35—$-0.20

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$8M$24M$41M$60M$52M$40M$51M$40M
Inventory$31M$32M$31M$21M$22M$7M$11M$715,000
Total current assets$212M$245M$285M$339M$281M$304M$334M$209M
Total assets$249M$288M$328M$373M$313M$327M$351M$218M
Long-term debt$97M$97M$96M$96M——$0—
Total liabilities$237M$226M$213M$225M$121M$98M$94M$17M
Total equity$13M$61M$114M$148M$192M$229M$257M$201M

Implied volatility — last 90 days

27%264%502%739%977% Jun 08 — IV 234% · EM ±30.9%Jun 09 — IV 117% · EM ±14.6%Jun 10 — IV 142% · EM ±16.7%Jun 11 — IV 99% · EM ±10.9%Jun 12 — IV 70% · EM ±7.2%Jun 15 — IV 85% · EM ±6.1%Jun 16 — IV 113% · EM ±6.7%Jun 17 — IV 73% · EM ±3.0%Jun 19 — IV 69% · EM ±15.3%Jun 22 — IV 96% · EM ±20.1%Jun 23 — IV 93% · EM ±19.0%Jun 24 — IV 102% · EM ±20.4%Jun 25 — IV 118% · EM ±23.1%Jun 26 — IV 101% · EM ±19.3%Jun 29 — IV 91% · EM ±16.1%Jun 30 — IV 101% · EM ±17.3%Jul 01 — IV 85% · EM ±14.2%Jul 02 — IV 199% · EM ±32.1%Jul 03 — IV 206% · EM ±32.1%Jul 07 — IV 120% · EM ±15.9%Jul 08 — IV 443% · EM ±55.6%Jul 09 — IV 148% · EM ±17.5%Jul 10 — IV 251% · EM ±27.7%Jul 13 — IV 70% · EM ±5.8%Jul 14 — IV 145% · EM ±10.5%Jul 15 — IV 645% · EM ±38.1%Jul 16 — IV 128% · EM ±5.4%Jul 20 — IV 113% · EM ±26.8%Jul 21 — IV 120% · EM ±27.9%Jul 22 — IV 112% · EM ±25.6%Jul 23 — IV 107% · EM ±24.2%Jul 24 — IV 126% · EM ±27.8%Jul 27 — IV 129% · EM ±26.9%Jul 28 — IV 112% · EM ±23.0%Jul 29 — IV 236% · EM ±47.2%Jul 30 — IV 101% · EM ±19.9%Jul 31 — IV 108% · EM ±20.6%Aug 03 — IV 142% · EM ±25.2%Aug 04 — IV 142% · EM ±24.4%Aug 05 — IV 179% · EM ±29.9%Aug 06 — IV 212% · EM ±34.2%Aug 07 — IV 343% · EM ±53.6%Aug 10 — IV 269% · EM ±37.2%Aug 11 — IV 350% · EM ±46.2%Aug 12 — IV 356% · EM ±44.6%Aug 13 — IV 482% · EM ±56.9%Aug 14 — IV 232% · EM ±25.7%Aug 17 — IV 595% · EM ±49.7%Aug 18 — IV 564% · EM ±40.8%Aug 19 — IV 833% · EM ±49.2%Aug 20 — IV 630% · EM ±26.3%Aug 24 — IV 92% · EM ±19.3%Aug 25 — IV 148% · EM ±30.3%Aug 26 — IV 211% · EM ±42.3%Aug 27 — IV 212% · EM ±41.5%Aug 28 — IV 104% · EM ±19.9%Aug 31 — IV 106% · EM ±18.8%Sep 01 — IV 98% · EM ±16.9%Sep 02 — IV 170% · EM ±28.4%Sep 03 — IV 109% · EM ±17.6%Sep 04 — IV 161% · EM ±25.1%Sep 07 — IV 180% · EM ±24.9%Sep 08 — IV 88% · EM ±11.6%Sep 09 — IV 90% · EM ±11.3%Sep 10 — IV 125% · EM ±14.8%Sep 11 — IV 124% · EM ±13.7%Sep 14 — IV 339% · EM ±28.3%Sep 15 — IV 276% · EM ±20.0%Sep 16 — IV 569% · EM ±33.6%Sep 17 — IV 977% · EM ±40.8%Sep 21 — IV 27% · EM ±5.7%Sep 22 — IV 98% · EM ±20.2%Sep 23 — IV 93% · EM ±18.6%Sep 28 — IV 266% · EM ±47.2%Sep 29 — IV 136% · EM ±23.3%Sep 30 — IV 188% · EM ±31.3%Oct 01 — IV 218% · EM ±35.2%Oct 07 — IV 302% · EM ±37.8%Oct 08 — IV 195% · EM ±23.0%

Sector peers

TTRX
Turn Therapeutics Inc.
$396M $10.28+1.3%
RLMD
Relmada Therapeutics, Inc.
$390M $3.27+1.9%
DMAC
DiaMedica Therapeutics Inc.
$450M $8.72+0.3%
EBS
Emergent BioSolutions Inc.
$363M $6.23+0.5%
EVMN
Evommune, Inc.
$472M $5.10-1.4%
BNTC
Benitec Biopharma Inc.
$334M $8.65+1.8%

SPRY earnings FAQ

What is SPRY's expected move for earnings?

Options currently price a move of about ±23.0%, or $0.93 per share either way from $4.03.

How does SPRY stock usually react to earnings?

Across the last 2 reports the average next-day move was ±7.9%, up 0 times and down 2 times.

What is SPRY's implied volatility?

SPRY's at-the-money implied volatility is about 195% based on the latest options snapshot.

View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in